Anaconda Biomed secures $56 million financing round with backing from Asabys, Omega Funds and others

PUBT · 3d ago
Anaconda Biomed secures $56 million financing round with backing from Asabys, Omega Funds and others
  • Anaconda Biomed closed a USD 56 million private financing to fund its neurovascular thrombectomy catheter portfolio.
  • Asabys Partners SGEIC SA participated via its Sabadell Asabys I vehicle alongside Omega Funds, Ysios Capital, FOCO, and CDTI.
  • Capital earmarked to complete the ATHENA pivotal IDE study for the ANA Funnel Catheter, advance development, secure regulatory approvals.
  • Barcelona-based Anaconda develops funnel catheter technology aimed at improving clot capture, reducing embolic complications, maximizing brain reperfusion in stroke.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asabys Partners SGEIC SA published the original content used to generate this news brief on September 23, 2026, and is solely responsible for the information contained therein.